145 related articles for article (PubMed ID: 34854877)
1. Infiltration of bone marrow space with chondromas mimicking progression of polycythemia vera.
Duy La PB; Low MSY
Blood; 2021 Dec; 138(22):2299. PubMed ID: 34854877
[No Abstract] [Full Text] [Related]
2. [Polycythemia and splenomegaly in a 51-year-old woman].
Ribera JM; Abella E; Lloreta J
Med Clin (Barc); 1995 Jul; 105(5):191-6. PubMed ID: 7630233
[No Abstract] [Full Text] [Related]
3. Patho-anatomical features of the bone marrow.
Lennert K; Nagai K; Schwarze EW
Clin Haematol; 1975 Jun; 4(2):331-51. PubMed ID: 1102191
[No Abstract] [Full Text] [Related]
4. Current diagnostic criteria for the chronic myeloproliferative disorders (MPD) essential thrombocythemia (ET), polycythemia vera (PV) and chronic idiopathic myelofibrosis (CIMF).
Michiels JJ; Bernema Z; Van Bockstaele D; De Raeve H; Schroyens W
Pathol Biol (Paris); 2007 Mar; 55(2):92-104. PubMed ID: 16919893
[TBL] [Abstract][Full Text] [Related]
5. Megakaryocytic morphology and clinical parameters in essential thrombocythemia, polycythemia vera, and primary myelofibrosis with and without JAK2 V617F.
Vytrva N; Stacher E; Regitnig P; Zinke-Cerwenka W; Hojas S; Hubmann E; Porwit A; Bjorkholm M; Hoefler G; Beham-Schmid C
Arch Pathol Lab Med; 2014 Sep; 138(9):1203-9. PubMed ID: 25171702
[TBL] [Abstract][Full Text] [Related]
6. Bone marrow biopsy (BMB). II. Bone marrow biopsy in myeloproliferative disorders.
Macavei I; Galatâr N
Morphol Embryol (Bucur); 1989; 35(2):117-27. PubMed ID: 2529429
[TBL] [Abstract][Full Text] [Related]
7. Value of cytogenetic abnormalities in post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a study of the MYSEC project.
Mora B; Giorgino T; Guglielmelli P; Rumi E; Maffioli M; Rambaldi A; Caramella M; Komrokji R; Gotlib J; Kiladjian JJ; Cervantes F; Devos T; Palandri F; De Stefano V; Ruggeri M; Silver RT; Benevolo G; Albano F; Cavalloni C; Barraco D; Merli M; Pietra D; Casalone R; Barbui T; Rotunno G; Cazzola M; Vannucchi AM; Passamonti F
Haematologica; 2018 Sep; 103(9):e392-e394. PubMed ID: 29622658
[No Abstract] [Full Text] [Related]
8. Unusually prolonged survival of a case of acute megakaryoblastic leukemia secondary to long-standing polycythemia vera.
Stamatopoulos K; Yataganas X; Papadaki T; Paterakis G
Leuk Res; 2002 Jul; 26(7):699-700. PubMed ID: 12008090
[No Abstract] [Full Text] [Related]
9. Bone marrow histopathology and biological markers as specific clues to the differential diagnosis of essential thrombocythemia, polycythemia vera and prefibrotic or fibrotic agnogenic myeloid metaplasia.
Michiels JJ
Hematol J; 2004; 5(2):93-102. PubMed ID: 15048058
[TBL] [Abstract][Full Text] [Related]
10. [Utility of bone marrow biopsy in the diagnosis of myeloproliferative neoplasm].
Tovar-Bobadilla JL; Ortiz-Hidalgo C
Gac Med Mex; 2016; 152(3):407-18. PubMed ID: 27335198
[TBL] [Abstract][Full Text] [Related]
11. Molecular characterization of a transformation from primary myelofibrosis into polycythemia vera: a case report.
Butler MJ; Roda PI; Dorion P
Blood; 2013 Jul; 122(2):297-8. PubMed ID: 23847190
[No Abstract] [Full Text] [Related]
12. [Prognostic value of bone marrow biopsy in chronic myeloproliferative disorders].
Bettini R; Marzetta K; Miglioranza A; Redaelli S; Maino C; Maffiolini A; Gorini M
Recenti Prog Med; 2003; 94(7-8):314-20. PubMed ID: 12868237
[TBL] [Abstract][Full Text] [Related]
13. Proactive steps to optimize the management of polycythemia vera and myelofibrosis.
Mesa RA
Clin Adv Hematol Oncol; 2019 Sep; 17(9):475-477. PubMed ID: 31549966
[No Abstract] [Full Text] [Related]
14. Polycythemia vera turning into myelofibrosis in an individual with Pelger-Huet anomaly of the leukocytes.
RADO JP; HAMMER S
Blood; 1959 Oct; 14():1143-50. PubMed ID: 14435748
[No Abstract] [Full Text] [Related]
15. Prognostic factors and models in polycythemia vera, essential thrombocythemia, and primary myelofibrosis.
Passamonti F
Clin Lymphoma Myeloma Leuk; 2011 Jun; 11 Suppl 1():S25-7. PubMed ID: 22035744
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis, risk stratification, and response evaluation in classical myeloproliferative neoplasms.
Rumi E; Cazzola M
Blood; 2017 Feb; 129(6):680-692. PubMed ID: 28028026
[TBL] [Abstract][Full Text] [Related]
17. Polycythaemia vera and myelosclerosis: a bone marrow study.
Roberts BE; Miles DW; Woods CG
Br J Haematol; 1969; 16(1):75-85. PubMed ID: 5795215
[No Abstract] [Full Text] [Related]
18. Polycythaemia vera and myelofibrosis.
Ikkala E; Rapola J; Kotilainen M
Scand J Haematol; 1967 Dec; 4(6):453-64. PubMed ID: 6082224
[No Abstract] [Full Text] [Related]
19. [Myeloproliferative disorders].
Binder D; Fehr J
Ther Umsch; 2004 Feb; 61(2):131-42. PubMed ID: 15018396
[TBL] [Abstract][Full Text] [Related]
20. Phenotype variability of patients with post polycythemia vera and post essential thrombocythemia myelofibrosis is associated with the time to progression from polycythemia vera and essential thrombocythemia.
Mora B; Giorgino T; Guglielmelli P; Rumi E; Maffioli M; Rambaldi A; Caramella M; Komrokji R; Gotlib J; Kiladjian JJ; Cervantes F; Devos T; Palandri F; De Stefano V; Ruggeri M; Silver RT; Benevolo G; Albano F; Cavalloni C; Barraco D; Pietra D; Barbui T; Rotunno G; Vannucchi AM; Passamonti F
Leuk Res; 2018 Jun; 69():100-102. PubMed ID: 29734070
[No Abstract] [Full Text] [Related]
[Next] [New Search]
